What is CBD? The effects explained – and what the Food Standards Agency said about the safety of cannabidiol products

FSA says it remains concerned about CBD due to a lack of studies on its use as a food

The FSA has taken another step in regulating the CBD market.

The FSA has published a listing CBD (cannabidiol) products he is working on to allow sale in the UK.

To date, no food products containing CBD – found in hemp and cannabis – have been authorized for sale in the UK.

Register to our NationalWorld Today newsletter

The newsletter mute the noise

Find out here what the FSA has said about the CBD market and how many products are on the list.

What is CBD?

Cannabidiol, known as CBD, is one of 113 cannabinoids identified in cannabis plants – and makes up 40% of the plant extract.

It is most commonly used to treat pain, anxiety, inflammation, and insomnia.

CBD extracts are available in UK shops, cafes and online in the form of oils, drops, gels, confectionery, baked goods and drinks.

Are CBD edibles safe, what has the FSA said?

Despite the ruling, FSA chief executive Emily Miles said the FSA “remains concerned about CBD” due to the lack of studies on it when consumed as food.

The FSA also stressed that it does not endorse products and that just because a product is on the list does not mean it will be allowed.

She added: “Although we haven’t yet received enough evidence to say that CBD is dangerous, there is also not enough evidence to show that it is safe.”

She said that with the CBD market growing rapidly, the FSA was working to bring the CBD industry into compliance.

She continued, “Today we have taken the next step in our pragmatic approach to ensuring CBD products are safe and what they say they are.

“We created the public list to help local authorities and traders prioritize which products to remove from sale. If a product is not on the list, it should be removed from sale because it is not attached to a credible marketing authorization application.

“But being on the list means the claim is credible and the FSA has, or expects to receive shortly, significant scientific evidence from the claimant with which to judge safety.

“I would like to stress that the FSA does not endorse products on the public list, and inclusion on the list does not guarantee that they will be permitted as they have not yet been fully assessed for their safety.

“But we have taken the initiative to publish the list so that local authorities, retailers and consumers can make informed judgments about what they are stocking and buying, as we gradually bring this growing market into line with the law.”

Which CBD products are on the public list?

The FSA has published a public list Thursday, March 31, 2022 – to show which products have a credible claim for clearance.

There are 3,536 products on the list, of which 3,479 are pending proof, including a range of gummies, tinctures and sprays.

The FSA is now calling on local authorities and retailers to help bring the CBD market into compliance by removing products that do not appear on the list or are marked as ‘removed’.

Any products on the list marked ‘validated’ or ‘pending proof’ may remain on the market in England and Wales, pending further review.

This list only applies to England and Wales.

What are the guidelines?

CBD products have no history of use before May 1997, so they must be assessed by the FSA before being sold in the UK.

The FSA advises consumers to “think carefully” before taking CBD products.

They also recommend that people in vulnerable groups, including pregnant and breastfeeding women and those taking medication, use it only under medical direction.

Although there have been very few scientific studies, some suggest that CBD could affect the liver if taken in higher doses.

As a precautionary measure, the FSA recommends that healthy adults take no more than 70mg per day, or around 28 drops of 5% CBD – unless a doctor has agreed on a higher dose. .

Source link

Rozella J. Cook